These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2454061)

  • 41. Characterization of the drug receptors of the purified skeletal muscle calcium channel.
    Striessnig J; Glossmann H
    Prog Clin Biol Res; 1988; 252():35-40. PubMed ID: 2450374
    [No Abstract]   [Full Text] [Related]  

  • 42. Calcium antagonist receptors. Clinical and physiological relevance.
    Wagner JA; Guggino SE; Reynolds IJ; Snowman AM; Biswas A; Olivera BM; Snyder SH
    Ann N Y Acad Sci; 1988; 522():116-33. PubMed ID: 2454047
    [No Abstract]   [Full Text] [Related]  

  • 43. The selectivity filter of a ligand-gated ion channel.
    Hucho F; Hilgenfeld R
    J Protein Chem; 1989 Jun; 8(3):327. PubMed ID: 2477008
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasticity of neuronal L-type calcium channels.
    Govoni S; Battaini F; Magnoni SM; Lucchi L; Rius RA; Trabucchi M
    Ann N Y Acad Sci; 1988; 522():187-98. PubMed ID: 2454053
    [No Abstract]   [Full Text] [Related]  

  • 45. Ca2+ influx following receptor activation.
    Meldolesi J; Clementi E; Fasolato C; Zacchetti D; Pozzan T
    Trends Pharmacol Sci; 1991 Aug; 12(8):289-92. PubMed ID: 1658997
    [No Abstract]   [Full Text] [Related]  

  • 46. About a new method to measure fractional Ca2+ currents through ligand-gated ion channels.
    Fucile S; Grassi F
    J Gen Physiol; 2009 Sep; 134(3):259-61; author reply 263-5. PubMed ID: 19720963
    [No Abstract]   [Full Text] [Related]  

  • 47. Voltage-dependent Ca2+ channels in primary cultures of cerebellar granule cells: modulatory action by an endogenous ligand.
    Sanna E; Hanbauer I
    Pharmacol Res Commun; 1988 Dec; 20(12):1085-6. PubMed ID: 2850583
    [No Abstract]   [Full Text] [Related]  

  • 48. Putative Ca2+ channels in cardiac membranes. Subcellular distribution of [3H]nitrendipine receptors.
    Haase H; Vetter R; Will H; Will-Shahab L
    Biomed Biochim Acta; 1986; 45(1-2):S223-6. PubMed ID: 2421716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different localization of receptors for omega-conotoxin and nitrendipine in rat brain.
    Takemura M; Fukui H; Wada H
    Biochem Biophys Res Commun; 1987 Dec; 149(3):982-8. PubMed ID: 2447889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence in brain of an endogenous ligand for nitrendipine-binding sites that modulates Ca2+ channel activity.
    Hanbauer I; Sanna E
    Ann N Y Acad Sci; 1988; 522():96-105. PubMed ID: 2454061
    [No Abstract]   [Full Text] [Related]  

  • 51. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.
    Triggle DJ; Janis RA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects.
    Snyder SH; Reynolds IJ
    N Engl J Med; 1985 Oct; 313(16):995-1002. PubMed ID: 2413355
    [No Abstract]   [Full Text] [Related]  

  • 53. Molecular properties of structure and regulation of the calcium channel.
    Lazdunski M; Barhanin J; Borsotto M; Cognard C; Cooper C; Coppola T; Fosset M; Galizzi JP; Hosey MM; Mourre C
    Ann N Y Acad Sci; 1988; 522():134-49. PubMed ID: 2454048
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.